Wockhardt Limited, a leading Indian pharmaceutical company, announced positive outcomes from its compassionate use program for Zidebactam/Cefepime, a novel antibiotic combination discovered in India. This program offers valuable insights into the drug’s potential to combat highly resistant bacterial infections. Treating Critically Ill Patients with XDR Pathogens Over the past year, Zidebactam/Cefepime was administered to 30 …